XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) Net Margin (2020 - 2022)

Updated

XBiotech's Net Margin was -820.45% in FY2022, down 725.78 percentage points from -94.67% in FY2021.

Analysis

XBiotech (XBIT) Net Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant data, Net Margin in earlier years was -94.67% in FY2021 (-69.17 pp) and -25.50% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.83%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.24%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 28.01%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 20.69%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 37.28%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 29.27%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 19.55%
10 XBiotech 58.23 Mn -439.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -753.45%
Jun 30, 2022 -761.05%
Mar 31, 2022 -1,079.00%
Dec 31, 2021 -143.71%
Sep 30, 2021 -72.16%
Jun 30, 2021 -113.10%
Mar 31, 2021 -52.95%
Dec 31, 2020 -34.88%
Sep 30, 2020 -23.95%
Jun 30, 2020 -44.16%
Mar 31, 2020 -0.11%
API Access

XBiotech Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY